PUBLICATIONS#

2024#

|

Genetic algorithms applied to translational strategy in metabolic-dysfunction associated steatohepatitis (MASH). Learning from mouse models

|

One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis and fibrosis in high‐risk population

2023#

|

Serum identification of At-Risk MASH: The Metabolomics-Advanced steatohepatitis fibrosis score (MASEF)

|

Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy

2022#

|

Metabolic subtypes of nonalcoholic fatty liver disease patients exhibit distinctive cardiovascular risk profiles

2020#

|

The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles

|

A novel serum metabolomic profile for the differential diagnosis if distal cholangiocarcinoma and pancreático ductal adenocarcinoma

|

Agonist of RORA Attenuates Non-Alcoholic Fatty Liver Progression in Mice via Upregulation of microRNA 122

|

CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort

2019#

|

Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis

|

Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis

|

Plasma miRNAs signature validation for early detection of colorectal cancer

2018#

|

Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis

|

Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice

|

Targeted UPLC-MS metabolic analysis of human faeces reveals novel low-invasive candidate markers for colorectal cancer

|

Metabolomic-based noninvasive serum tests to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts

|

Use of a Metabolomic Approach to Non-invasively Diagnose Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

2017#

|

Role of aramchol in steatohepatitis and fibrosis in mice

|

Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

|

A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients

|

Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis

2016#

|

Metabolically active extracellular vesicles released from hepatocytes under drug-induced liver-damaging conditions modify serum metabolome and might affect different pathophysiological processes

2015#

|

Enhancing metabolomics research through data mining

|

Data in support of enhancing metabolomics research through data mining

2013#

|

Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis

|

Solute carrier family 2 member 1 (SLC2A1) is involved in the development of nonalcoholic fatty liver disease

2012#

|

Metabolic profile associated with alcoholic hepatitis and the response to treatment. Preliminary results

|

Obesity dependent metabolic signatures associated with nonalcoholic fatty liver disease progression